TARDBP and Guillain-Barre syndrome: A third study aimed to differentially diagnose ALS patients from GBS by quantitative determination of TDP-43 in the CSF, again using an ELISA-based approach [33] (detailed information on cohort selection size and composition, as well as used technique/antibody and detected TDP-43 levels can be found in Table 2).